← Back to headlines
Celcuity Expands VIKTORIA-2 Trial, Awaits FDA Decision for Gedatolisib
Celcuity has outlined the expansion of its VIKTORIA-2 trial and is anticipating an FDA decision for its drug gedatolisib by July 17.
15 May, 00:22 — 15 May, 00:22
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Phivolcs logs surge in toxic gas emission from Taal Volcano
just now
UP Chemists Develop AI Tool to Combat Antimicrobial Resistance
just now
Satellite Images Reveal Ancient Tombs in Sahara Desert
19m ago